Mini-puberty is often reduced to a transient testosterone surge. Clinically, it is much more useful to think of it as a temporary systems-level test of the reproductive axis.

In this episode of Pediatric Urology Academy, we examine how LH and FSH, Leydig-cell markers, Sertoli-cell markers, and the infant phenotype can be integrated to distinguish different mechanisms of gonadal dysfunction.

The discussion focuses on micropenis, bilateral cryptorchidism, bilateral nonpalpable testes, congenital hypogonadotropic hypogonadism, and the diagnostic value of AMH and inhibin B when the classic testosterone window has begun to fade.

We also examine an important controversy: whether abnormal mini-puberty truly explains impaired germ-cell development in cryptorchid boys, and how far the evidence supports hormonal treatment in infancy.

The central message is simple:

Mini-puberty is not one hormone peak.

There is no single mini-puberty clock.

And in infancy, time is part of the test itself.

Pediatric Urology Academy
Hosted by Amin Afrasiabi, MD.

“Bilateral nonpalpable testes should trigger more than a localization strategy. This episode examines the diagnostic reasoning before laparoscopy: phenotype, mini-puberty, Sertoli and Leydig markers, anorchia, congenital hypogonadotropic hypogonadism, DSD, and the limitations of ultrasound. The clinical framework is simple: central signal → Leydig function → Sertoli function → anatomy.”

A 46,XY karyotype tells you the chromosomes. It does not tell you whether a functional testis formed, whether Sertoli and Leydig signaling occurred normally, whether testosterone was converted to DHT, or whether androgen action was intact.

This episode builds a mechanistic framework for evaluating 46,XY DSD by tracing the biological signal from gonadal determination to phenotype.

The practical goal is simple: stop memorizing syndromes and identify where the biological signal failed.

When should hypospadias trigger a DSD evaluation?

Proximal hypospadias alone is not synonymous with a difference of sex development. But the diagnostic probability changes substantially when the phenotype includes cryptorchidism, bifid scrotum, micropenis, genital asymmetry, or other discordant features.

In Season 5, Episode 2 of Pediatric Urology Academy, we examine how to read the genital phenotype across three axes: urethral anatomy, gonadal position, and overall masculinization.

The episode explores why bilateral undescended testes with severe hypospadias should move the clinician beyond reconstructive planning toward endocrine and genetic reasoning; why unilateral cryptorchidism represents a more nuanced diagnostic zone; and why descended testes reduce—but do not eliminate—the possibility of an identifiable molecular diagnosis.

The central principle: phenotype changes probability; it does not establish etiology.

Pediatric Urology Academy
Season 5 — DSD, Cryptorchidism and the Undescended Gonad
Hosted by Amin Afrasiabi, MD

Educational content for healthcare professionals. Not individual medical advice.

A newborn with atypical genitalia creates diagnostic urgency. But what actually requires immediate action?

In the opening episode of Season 5 of Pediatric Urology Academy, we separate three timelines that are often confused: physiological emergency, diagnostic evaluation, and irreversible intervention.

We examine why normal electrolytes on the first day of life do not exclude evolving salt-wasting congenital adrenal hyperplasia, why bilateral nonpalpable gonads should trigger biological and endocrine reasoning before surgical localization, and why severe hypospadias changes the probability of DSD without establishing the diagnosis.

The central framework is simple: protect physiology first, establish biology next, define anatomy after that, and only then consider irreversible intervention.

Pediatric Urology Academy
Season 5 — DSD, Cryptorchidism and the Undescended Gonad
Hosted by Amin Afrasiabi, MD

Educational content for clinicians. Not individual medical advice.

When does surgery provide durable local control in bladder–prostate rhabdomyosarcoma without imposing unnecessary functional cost?

This educational episode reviews the surgical decision points in BP-RMS, including diagnostic biopsy, induction therapy, local-control selection, delayed primary excision, organ-preserving surgery, radiotherapy, interpretation of residual masses, bladder outcomes, radical surgery, urinary reconstruction, and management of relapse.

The central principle is response-adapted, multidisciplinary local control: resect only when surgery meaningfully improves oncologic control without unacceptable functional morbidity.

Presented by Amin Afrasiabi, MD — Pediatric Urology.

Intended for pediatric urologists, pediatric oncologists, radiation oncologists, surgeons, trainees, and multidisciplinary sarcoma teams.

Educational disclaimer: This presentation is intended for healthcare-professional education. It does not replace current cooperative-group protocols, multidisciplinary assessment, institutional guidance, or individualized clinical decision-making.

Key sources include contemporary INSTRuCT guidance, NCI Childhood Rhabdomyosarcoma resources, and peer-reviewed literature cited within the presentation.

Hypospadias surgery is usually performed in infancy, but the most meaningful outcomes may not appear until adolescence or adulthood.

This episode asks a difficult question: are pediatric urologists declaring success before the patient has reached the age when success truly matters?

We discuss puberty, recurrent curvature, urinary stream, strictures, spraying, penile appearance, body image, sexual confidence, fertility anxiety, partner perception, and why adult follow-up changes how we should judge childhood repair.

This episode is part of Season 4 of Pediatric Urology Academy: Hypospadias — Anatomy, Judgment, and Reconstruction.

A hypospadias repair may look successful in the postoperative photograph and still fail the patient later.

This episode asks whether cosmetic success, anatomic success, urinary success, and patient success are the same outcome.

We discuss HOSE, PPPS, urinary stream, meatal position, glans shape, uroflow, parent satisfaction, surgeon satisfaction, adolescent perception, body image, sexual confidence, and why short-term pediatric follow-up may miss the outcomes that matter most.

This episode is part of Season 4 of Pediatric Urology Academy: Hypospadias — Anatomy, Judgment, and Reconstruction.

Redo hypospadias is not primary hypospadias repeated.

The anatomy may look familiar, but the biology has changed. Scar, altered vascularity, consumed dartos, stiff glans wings, recurrent curvature, strictures, diverticula, fistulas, and prior tissue choices all change the operation.

This episode reframes redo hypospadias as a different reconstructive disease.

We discuss a five-failure framework: flow failure, tissue failure, coverage failure, curvature failure, and expectation failure.

The goal is not simply to close the visible defect. The goal is to understand why the previous repair failed before creating the next repair.

This episode is part of Season 4 of Pediatric Urology Academy: Hypospadias — Anatomy, Judgment, and Reconstruction.

Urethrocutaneous fistula after hypospadias repair is often described as an unpredictable complication.

This episode argues the opposite.

Fistula is usually the visible endpoint of pressure, ischemia, tension, distal obstruction, hematoma, catheter stress, or inadequate vascular coverage.

We discuss dartos, tunica vaginalis, second-layer coverage, non-overlapping suture lines, glans pressure, dressing strategy, catheter-related stress, bladder spasms, distal narrowing, and why fistula prevention should be understood as engineering rather than luck.

This episode is part of Season 4 of Pediatric Urology Academy: Hypospadias — Anatomy, Judgment, and Reconstruction.